Browse articles from EyeWorld.org related to allergies. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
While true allergies to materials used during cataract surgery are uncommon, this is a topic that physicians may need to discuss with patients. Two physicians highlighted some of the key concerns they hear from patients and how they approach these to identify real allergies versus intolerances.
➤ Topline results for investigational first-in-class dry eye drop ➤ Dosing complete in second cohort of Stargardt disease gene therapy trial ➤ Enrollment complete for Phase 2 acute optic neuritis trial ➤ Enrollment complete for Phase 1/2a trial evaluating neovascular AMD therapy ➤ ASCRS news and events
➤ Positive topline results in Phase 3 clinical trial for allergic conjunctivitis treatment ➤ Phase 1b topline data on investigational dry eye drop ➤ First patients dosed in Phase 1b/2 trial for Wnt agonist antibody ➤ Study: U.S. prevalence of diabetic retinopathy ➤ ASCRS news and events
➤ Phase 3 clinical trial results for once-daily netarsudil ophthalmic solution ➤ Dexamethasone ophthalmic insert approved for new indication ➤ Results from home OCT feasibility study ➤ FDA accepts application for brolucizumab for DME ➤ Companies form alliance to develop nomograms, lens constants and astigmatism calculations ➤ AAO announces next CEO ➤ ASCRS news and events
➤ FDA grants De Novo authorization for new intense pulsed light device ➤ Post-approval study requirements fulfilled for clear corneal incision sealant ➤ Interim analysis for acute adenoviral conjunctivitis drug ➤ NDA resubmission for injection to treat macular edema associated with uveitis ➤ FDA approves abbreviated NDA for glaucoma drug ➤ Study: Functional and psychosocial impact of Demodex blepharitis ➤ Next ASCRS Journal Club on May 13
➤ Positive topline results for Phase 3 trial of drug for allergic conjunctivitis ➤ Phase 2 trial of progesterone topical gel for DED begins ➤ Breakthrough Device Designation granted to remote glaucoma management system ➤ Glaukos enters into licensing agreement for presbyopia treatment ➤ Increase in laser vision correction procedures continues ➤ Guide on climate change and eye health ➤ ASCRS events
➤ Phase 2 clinical trial of minocycline for MGD ➤ Phase 2a study of drug-eluting contact lens for glaucoma ➤ Phase 1/2 results of RNA therapy for Usher syndrome, non-syndromic retinitis pigmentosa ➤ First regulatory approval for a therapeutic contact lens that treats ocular allergies ➤ Moist heat masks effective for signs, symptoms of dry eye, study finds ➤ ASCRS Journal Club on April 8
Vernal keratoconjunctivitis is a condition that usually presents in young children. It is one of the less common forms of allergic conjunctivitis, however, it arguably has some of the most significant and serious signs and symptoms. Victor Pegado, MD, described signs and how to handle these cases.
As allergies increase worldwide and as ocular allergies garner greater attention, more of your patients may use oral medications or intranasal steroids in addition to topical eye drops for allergic rhinoconjunctivitis. However, it would be prudent to monitor who among your patients is prescribed these allergy treatments.